A share price of Conduit Pharmaceuticals Inc [CDT] is currently trading at $0.12, up 50.37%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CDT shares have gain 62.88% over the last week, with a monthly amount glided 36.54%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Conduit Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $0.05 and $5.16. Conduit Pharmaceuticals Inc [NASDAQ: CDT] shares were valued at $0.12 at the most recent close of the market.
Analyzing the CDT fundamentals
Gross Profit Margin for this corporation currently stands at 0.49% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at -0.01%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -4.56, Equity is 3.01 and Total Capital is 1.42. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.26.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.0880 points at the first support level, and at 0.0527 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.1709, and for the 2nd resistance point, it is at 0.2185.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Conduit Pharmaceuticals Inc [NASDAQ:CDT] is 0.12. As well, the Quick Ratio is 0.12, while the Cash Ratio is 0.01.
Transactions by insiders
Recent insider trading involved Nirland Ltd, 10% Owner, that happened on Oct 03 ’24 when 1.5 million shares were sold. 10% Owner, Nirland Ltd completed a deal on Oct 04 ’24 to sell 1.37 million shares. Meanwhile, 10% Owner Nirland Ltd sold 0.94 million shares on Oct 07 ’24.
